Cellectar Biosciences Announces US and Japanese Patent Allowances for Diagnostic and Optical Imaging PDCs Pharmaceutical Investing
Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites for Oral Prurisol Treatment of Moderate-To-Severe Psoriasis Pharmaceutical Investing
Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B Pharmaceutical Investing
Tonix Pharmaceuticals’ PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation by the FDA Life Science Investing
MediciNova Announces Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Will Continue Pharmaceutical Investing
Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA Pharmaceutical Investing
Novartis Receives Positive CHMP Recommendation for Ilaris® to Treat Periodic Fever Syndromes Life Science Investing
